Vitamin D3 supplementation improves glycemic control in type 2 diabetic patients: Results from an Italian clinical trial
Abstract
Abstract.Background: to evaluate the effects of Vitamin D3 on glyco-metabolic control in type 2 diabetic patients with Vitamin D deficiency. Methods: one hundred and seventeen patients were randomized to placebo and 122 patients to Vitamin D3. We evaluated anthropometric parameters, glyco-metabolic control, and parathormone (PTH) value at baseline, after 3, and 6 months. Results: a significant reduction of fasting, and post-prandial glucose was recorded in Vitamin D3 group after 6 months. A significant HbA1c decrease was observed in Vitamin D3 (from 7.6% or 60 mmol/mol to 7.1% or 54 mmol) at 6 months compared to baseline, and to placebo (p < 0.05 for both). At the end of the study period, we noticed a change in the amount in doses of oral or subcutaneous hypoglycemic agents and insulin, respectively. The use of metformin, acarbose, and pioglitazone was significantly lower (p = 0.037, p = 0.048, and p = 0.042, respectively) than at the beginning of the study in the Vitamin D3 therapy group. The units of Lispro, Aspart, and Glargine insulin were lower in the Vitamin D3 group at the end of the study (p = 0.031, p = 0.037, and p = 0.035, respectively) than in the placebo group. Conclusions: in type 2 diabetic patients with Vitamin D deficiency, the restoration of value in the Vitamin D standard has led not only to an improvement in the glyco-metabolic compensation, but also to a reduced posology of some oral hypoglycemic agents and some types of insulin used.
References
1 . IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311–21.
2 Intensive glucose control in patients with type 2 diabetes-15-year follow-up. N Engl J Med. 2019;380(23):2215–24.
3 . Il diabete in Italia: Report 2000–2016. Available from: https://www.istat.it/it/files/2017/07/REPORT_DIABETE.pdf
4 The relative burden of diabetes complications on healthcare costs: The population-based CINECA-SID ARNO Diabetes Observatory. Nutr Metab Cardiovasc Dis. 2016;26(10):944–50.
5 The burden of hospitalization related to diabetes mellitus: A population-based study. Nutr Metab Cardiovasc Dis. 2012;22(7):605–12.
6 . Vitamin D deficiency. N Engl J Med. 2007;357(3):266–81.
7 . Role of Vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol. 2010;2010:351385.
8 . Identification of a Vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol. 2003;84(2–3):223–30.
9 . Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79(5):820–5.
10 . Vitamin D deficiency in obese children and its relationship to insulin resistance and adipokines. J Obes. 2011;2011:495101.
11 . Baseline serum 25-hydroxy Vitamin D is predictive of future glycemic status and insulin resistance: The Medical Research Council Ely Prospective Study 1990–2000. Diabetes. 2008;57(10):2619–25.
12 . Vitamin D status and glucose homeostasis in the 1958 British birth cohort: The role of obesity. Diabetes Care. 2006;29(10):2244–6.
13 . Vitamin D and diabetes: Where do we stand? Diabetes Res Clin Pract. 2015;108(2):201–9.
14 . Vitamin D deficiency and diabetes. Biochem J. 2017;474(8):1321–32.
15 . Vitamin D and insulin resistance. Clin Endocrinol. 2016;84(2):159–71.
16 Proposed International Guidelines for Biomedical Research Involving Human Subjects. Geneva: Council for International Organisation of Medical Sciences; 1982.
17 . Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: Executive summary. Eur Heart J. 2007;28(1):88–136.
18 Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS). Guidelines on prevention and treatment of Vitamin D deficiency. Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS). Reumatismo. 2011;63(3):129–47.
19 Summary of American Heart Association Diet and Lifestyle Recommendations Revision 2006. Arterioscler Thromb Vasc Biol. 2006;26:2186–91.
20 . A desktop guide to type 2 diabetes mellitus. Diabet Med. 1999;16:716–30.
21 . The glycosylation of haemoglobin. Relevance to diabetes mellitus. Science. 1978;200:21–7.
22 . Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia. 1972;8:260–6.
23 . Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.
24 . Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487–95.
25 . Enzymatische Bestimmung des Gesamtcholesterins mit dem Greiner Selective Analyzer (GSA-II).
[Enzymatic determination of total cholesterol with the Greiner Selective Analyzer (GSA-II)] . J Clin Chem Clin Biochem. 1978;15:121–30.26 .
Triglycerides determination after enzymatic hydrolysis . In: Bergmeyer HU, editor. Methods of enzymatic analysis. New York: Academic Press; 1974. p. 18–31.27 . The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345–53.
28 . Estimation of the concentration of low density lipoprotein in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.
29 Effect of serum parathyroid hormone on tacrolimus therapy in kidney transplant patients: A possible biomarker for a tacrolimus dosage schedule. Biol Pharm Bull. 2019;42(5):786–91.
30 Determining vitamin D status: A comparison between commercially available assays. PLoS One. 2010;5(7):e11555.
31 . Statistical principles in experimental design. 2nd ed. New York, USA: McGraw-Hill Publishing; 1971.
32 . Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr. 2009;48:349–54.
33 . A prospective randomized controlled trial of the effects of Vitamin D supplementation on long-term glycemic control in type 2 diabetes mellitus of Korea. Endocr J. 2014;61(2):167–76.
34 . The effect of high-dose Vitamin D supplementation on insulin resistance and arterial stiffness in patients with type 2 diabetes. Korean J Intern Med. 2014;29:620–9.
35 . Vitamin D deficiency, serum leptin and osteoprotegerin levels in older diabetic patients: An input to new research avenues. Acta Diabetol. 2014;51:461–9.
36 Vitamin D supplementation in obese type 2 diabetes subjects in Ajman, UAE: A randomized controlled double-blinded clinical trial. Eur J Clin Nutr. 2015;69:707–11.
37 Effect of Vitamin D supplementation on glycemic control in patients with type 2 diabetes (SUNNY Trial): A randomized placebo-controlled trial. Diabetes Care. 2015;38:1420–6.
38 . the renin-angiotensin system, and insulin resistance. Int Urol Nephrol. 2008;40:419–26.
39 . 1alpha,25-dihydroxyVitamin D3 inhibits uncoupling protein 2 expression in human adipocytes. Faseb J. 2002;16:1808–10.
40 . Vitamin D and insulin resistance. Clin Endocrinol. 2016;84:159–71.
41 . Inadequate Vitamin D status: Does it contribute to the disorders comprising syndrome ‘X’? Br J Nutr. 1998;79(4):315–27.
42 . Serum 25-hydroxyVitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract. 1995;27(3):181–8.
43 . Regulation of adiposity by dietary calcium. Faseb J. 2000;14(9):1132–8.
44 . Glucose intolerance and impairment of insulin secretion in relation to Vitamin D deficiency in east London Asians. Diabetologia. 1995;38(10):1239–45.
45 . Cellular mechanisms of insulin release: The effects of Vitamin D deficiency and repletion on rat insulin secretion. Endocrinology. 1983;113(4):1511–8.
46 . Control of renin synthesis. Am J Physiol Regul Integr Comp Physiol. 2003;285(3):R491–7.
47 . Vitamin D3 improves impaired glucose tolerance and insulin secretion in the Vitamin D-deficient rat in vivo. Endocrinology. 1986;119(1):84–90.
48 . The de novo synthesis of numerous proteins is decreased during Vitamin D3 deficiency and is gradually restored by 1,25- dihydroxyVitamin D3 repletion in the islets of Langerhans of rats. J Endocrinol. 1999;162(1):101–9.
49 Survival after the diagnosis of hyperparathyroidism: A population-based study. Am J Med. 1998;104(2):115–22.
